Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administration of
Canagliflozin (TA-7284) and Teneligliptin (MP-513) once daily for 24 weeks in Japanese
patients with Type 2 diabetes mellitus who are receiving treatment with Canagliflozin and
have inadequate glycemic control.